User:Kku/NantWorks
< User:Kku
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
NantWorks LLC founded in 2007[1] is an American multinational conglomerate holding company. It owns a number of technology companies in the fields of healthcare, commerce, digital entertainment as well as a venture capital firm in the healthcare, education, science, and technology sectors. Particular technologies include machine vision, object and voice recognition, low power semiconductors, supercomputing, and networking technologies.[2]
The Chairman, CEO, and founder of NantWorks is South African born physician Patrick Soon-Shiong.[1]
| Company type | Private |
|---|---|
| Industry | Conglomerate |
| Founded | 2007 |
| Headquarters | , |
Key people | Patrick Soon-Shiong (founder) |
| Products | |
| Subsidiaries |
|
| Website | nantworks |
The constituent companies of the NantWorks Group are:
- NantHealth
- NantCloud (est. 2010, acquired by NantHealth in 2015, healthcare cloud computing)[citation needed]
- NantOmics
- NantBioScience
- NantCell
- NantKwest Inc., now ImmunityBio (immunotherapy for treatment of cancers, infectious, and inflammatory diseases[3][4][5])
- NantPharma (also: Nant Pharma) LLC (est. 2012 with investments from Blackstone,[6] manufactures and markets crude heparin, biologically derived pharmaceuticals including critical care injectable and oncological drugs.,[7][8] exclusive license agreement with AmGen[9])
- NantMobile (mobile marketing)[10]
- NantCapital (also: Nant Capital) LLC (est. 2012, investment and venture capital,[11] owner of Los Angeles Times and San Diego Union Tribune[12]) and
- ImmunityBio[13]
References
[edit]- ^ a b Lawrence, Stacy (2015-05-13). "Dr. Patrick Soon-Shiong - NantWorks". FierceBiotech. Retrieved 2019-07-09.
- ^ "NantWorks LLC - Company Profile and News". Bloomberg News.
- ^ "Cell Therapy for Cancer". ImmunityBio. 2023-01-26. Retrieved 2023-02-02.
- ^ "Symbol Lookup from Yahoo Finance".
- ^ "NK: ImmunityBio Inc Stock Price Quote - Bloomberg". Bloomberg News.
- ^ * "Blackstone Invests $125 Million in Nantpharma, A Nantworks Company". blackstone.com. Retrieved 2023-02-02.
- ^ "NantPharma LLC - Company Profile and News". Bloomberg News.
- ^ "Development and manufacturing of superior quality, injectable pharmaceuticals". nantpharma. 2012-02-21. Archived from the original on 2022-12-09. Retrieved 2023-02-02./
- ^ "NantWorks Enters into Exclusive License Agreement with Amgen to Target Cancer c-Met Receptor". 14 September 2015.
- ^ "NantMobile, LLC". NantMobile, LLC. Retrieved 2023-02-02.
- ^ "Nant Capital LLC - Company Profile and News". Bloomberg News.
- ^ "Nant Capital LLC buys Los Angeles Times from tronc inc". Orange County Breeze. 2018-07-24. Retrieved 2019-07-09.
- ^ "NantKwest and ImmunityBio Announce Therapeutics and Vaccines for Combatting COVID-19; Clinical Trials Anticipated to Begin This Quarter". BioSpace.com. 14 April 2020.
External links
[edit]- "NantWorks". NantWorks. 2023-01-10. Retrieved 2023-02-02.